Related Experiment Video
Updated: Aug 13, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
From algorithm to alarm: a narrative review on insulin delivery innovation
Noor Ul Ain Saleem1, Faraz Arshad2, Maria Qadri3
1Department of Medicine, FMH College of Medicine and Dentistry, Lahore, Pakistan.
Annals of Medicine and Surgery (2012)
|August 12, 2026
Summary
Closed-loop insulin delivery systems offer superior diabetes management by autonomously regulating blood glucose. These advanced technologies improve glycemic control and reduce hypoglycemia compared to sensor-augmented pumps.
Area of Science:
- Endocrinology and Metabolic Diseases
- Biomedical Engineering
- Medical Device Technology
Background:
- Rising global diabetes incidence demands improved management strategies.
- Traditional insulin therapy faces challenges in glycemic control and hypoglycemia risk.
- Insulin delivery systems, particularly advanced ones, are crucial for effective diabetes care.
Purpose of the Study:
- To review the development, clinical utility, and limitations of insulin delivery systems.
- To focus on sensor-augmented and closed-loop insulin technologies.
- To compare the efficacy of closed-loop systems versus sensor-augmented pump therapy.
Main Methods:
- A comprehensive literature search of electronic databases was performed.
- Data on major insulin delivery devices, including sensor-augmented and closed-loop systems, were analyzed.
- Both qualitative and quantitative data were examined to synthesize findings.
Main Results:
- Closed-loop systems integrate insulin pumps, algorithms, and continuous glucose monitoring for autonomous glucose regulation.
- Closed-loop devices demonstrated superior performance over sensor-augmented pump (SAP) therapy in reducing hypoglycemia and increasing time-in-range.
- AI-powered algorithms in closed-loop systems dynamically adjust insulin delivery, enhancing glycemic control and reducing variability.
Conclusions:
- Sensor-augmented and closed-loop insulin devices represent significant advancements in diabetes care.
- Closed-loop insulin delivery systems show greater clinical success in managing diabetes mellitus compared to SAP therapy.
- These advanced systems offer improved glucose control and reduced hypoglycemia rates.
Related Concept Videos
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
01:25Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:06Oral Hypoglycemic Agents: Glinides
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
01:24Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
01:05Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...